Nonlactating-cow therapy with a formulation of penicillin and novobiocin: mammary irritation and residues.
An experimental product incorporating 500,000 IU of procaine penicillin G and 600 mg of sodium novobiocin in 2% aluminum monostearate-peanut oil gel (10-ml dose) was infused after the final milk-out at end of lactation into all 4 mammary quarters of 56 cows that were infected in at least 1 quarter. The therapeutic and prophylactic efficacies were published in the companion report. Infusion of the product in all quarters of 5 lactating cows resulted in only slight irritation. Penicillin was eliminated by the 11th milking and novobiocin by the 5th. After infusion in the dry udder, the antibiotics were no longer detectable in serous secretion after 14 days and failed to appear in urine at the earliest (7-day) sampling after administration. Neither antibiotic was detectable in the 1st postpartum milking after nonlactating periods as short as 3 weeks.
D000818:Animals; D002417:Cattle; D004338:Drug Combinations; D005260:Female; D007249:Inflammation; D007774:Lactation; D008321:Mammary Glands, Animal / Q000378:metabolism; D008414:Mastitis, Bovine / Q000517:prevention & control*; D009675:Novobiocin / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism*; D010402:Penicillin G Procaine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism*; D011247:Pregnancy
D004338:Drug Combinations; D009675:Novobiocin; D010402:Penicillin G Procaine